Creatine kinase (U/L) | <170 | 170–999 | 1,000–5,000 | >5,000 |
---|---|---|---|---|
Count (n) | 398 | 1029 | 283 | 59 |
Gender: men (%) | 212 (53.9%) | 676 (66.3%) | 192 (68.6%)* | 45 (77.6%)* |
Age | 65 (53–73) | 66 (55–74) | 62 (50–71) | 63 (46–71) |
ICU stay (days) | 2 (1–6) | 2 (1–4) | 3 (1–9)* | 6 (3–14)* |
SOFA | 5 (2–8) | 6 (4–9) | 7 (4–10)* | 9 (5–13)* |
AKI (%) | 56 (14.1%) | 181 (17.5%) | 83 (29.3%)* | 25 (42.4%)* |
Hemodialysis (%) | 34 (8.5%) | 56 (5.4%) | 33 (11.7%) | 25 (42.4%)* |
Mortality (%) | 35 (8.8%) | 51 (5%) | 33 (11.7%) | 16 (27.1%)* |